Literature DB >> 21102268

Treatment of lung cancer with an ALK inhibitor after EML4-ALK fusion gene detection using endobronchial ultrasound-guided transbronchial needle aspiration.

Takahiro Nakajima1, Hideki Kimura, Kengo Takeuchi, Manabu Soda, Hiroyuki Mano, Kazuhiro Yasufuku, Toshihiko Iizasa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21102268     DOI： 10.1097/JTO.0b013e3181f77b58

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  10 in total

Review 1.  Acquisition and processing of endobronchial ultrasound-guided transbronchial needle aspiration specimens in the era of targeted lung cancer chemotherapy.

Authors:  William Bulman; Anjali Saqi; Charles A Powell
Journal:  Am J Respir Crit Care Med       Date:  2011-10-27       Impact factor: 21.405

Review 2.  New strategies for treatment of ALK-rearranged non-small cell lung cancers.

Authors:  Takaaki Sasaki; Pasi A Jänne
Journal:  Clin Cancer Res       Date:  2011-10-18       Impact factor: 12.531

Review 3.  Current status and perspective of EBUS-TBNA.

Authors:  Takahiro Nakajima; Kazuhiro Yasufuku; Ichiro Yoshino
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-02-26

4.  Protein Kinase Cι Drives a NOTCH3-dependent Stem-like Phenotype in Mutant KRAS Lung Adenocarcinoma.

Authors:  Syed A Ali; Verline Justilien; Lee Jamieson; Nicole R Murray; Alan P Fields
Journal:  Cancer Cell       Date:  2016-03-14       Impact factor: 31.743

Review 5.  Crizotinib for the treatment of ALK-rearranged non-small cell lung cancer: a success story to usher in the second decade of molecular targeted therapy in oncology.

Authors:  Sai-Hong Ignatius Ou; Cynthia Huang Bartlett; Mari Mino-Kenudson; Jean Cui; A John Iafrate
Journal:  Oncologist       Date:  2012-09-18

6.  An official American Thoracic Society/European Respiratory Society statement: the role of the pulmonologist in the diagnosis and management of lung cancer.

Authors:  Mina Gaga; Charles A Powell; Dean E Schraufnagel; Nicolas Schönfeld; Klaus Rabe; Nicholas S Hill; Jean-Paul Sculier
Journal:  Am J Respir Crit Care Med       Date:  2013-08-15       Impact factor: 21.405

7.  KLC1-ALK: a novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue only.

Authors:  Yuki Togashi; Manabu Soda; Seiji Sakata; Emiko Sugawara; Satoko Hatano; Reimi Asaka; Takashi Nakajima; Hiroyuki Mano; Kengo Takeuchi
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

8.  Efficient utilization of EBUS-TBNA samples for both diagnosis and molecular analyses.

Authors:  F Oezkan; Am Khan; P Zarogoulidis; W Hohenforst-Schmidt; D Theegarten; K Yasufuku; T Nakajima; L Freitag; K Darwiche
Journal:  Onco Targets Ther       Date:  2014-11-10       Impact factor: 4.147

Review 9.  Staging lung cancer: role of endobronchial ultrasound.

Authors:  Terunaga Inage; Takahiro Nakajima; Ichiro Yoshino
Journal:  Lung Cancer (Auckl)       Date:  2014-11-04

10.  Clinical use of crizotinib for the treatment of non-small cell lung cancer.

Authors:  Patrick J Roberts
Journal:  Biologics       Date:  2013-04-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.